219 related articles for article (PubMed ID: 37175780)
41. New nonchemotherapy treatment options for cutaneous T-cell lymphomas.
Xu S; Foss F
Expert Rev Anticancer Ther; 2021 Sep; 21(9):1017-1028. PubMed ID: 33554707
[TBL] [Abstract][Full Text] [Related]
42. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature.
Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE
J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851
[TBL] [Abstract][Full Text] [Related]
43. Functional Depletion of HSP72 by siRNA and Quercetin Enhances Vorinostat-Induced Apoptosis in an HSP72-Overexpressing Cutaneous T-Cell Lymphoma Cell Line, Hut78.
Fujii K; Idogawa M; Suzuki N; Iwatsuki K; Kanekura T
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681913
[TBL] [Abstract][Full Text] [Related]
44. Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides.
Foss F; Duvic M; Lerner A; Waksman J; Whittaker S
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):637-643. PubMed ID: 27637428
[TBL] [Abstract][Full Text] [Related]
45. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
[TBL] [Abstract][Full Text] [Related]
46. Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study.
Elmasry MF; Obaid YA; El-Samanoudy SI; Nour ZA; Doss SS
Arch Dermatol Res; 2024 Jun; 316(7):349. PubMed ID: 38850434
[TBL] [Abstract][Full Text] [Related]
47. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.
Asadullah K; Haeussler-Quade A; Gellrich S; Hanneken S; Hansen-Hagge TE; Döcke WD; Volk HD; Sterry W
Exp Dermatol; 2000 Aug; 9(4):248-51. PubMed ID: 10949545
[TBL] [Abstract][Full Text] [Related]
48. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update.
Ramelyte E; Dummer R; Guenova E
Expert Opin Investig Drugs; 2019 Sep; 28(9):799-809. PubMed ID: 31398295
[No Abstract] [Full Text] [Related]
49. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
50. Successful treatment of syringotropic CD8+ mycosis fungoides accompanied by hypohidrosis with vorinostat and retinoids.
Kakizaki A; Fujimura T; Mizuashi M; Watabe A; Kambayashi Y; Aiba S
Australas J Dermatol; 2013 Nov; 54(4):e82-4. PubMed ID: 22963521
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
52. Mycosis on mycosis fungoides: zoophilic dermatophytosis selectively superimposed on pre-existing cutaneous T-cell lymphoma (mycosis fungoides) plaques.
Capella GL; Altomare GF
Mycoses; 2003 Feb; 46(1-2):67-70. PubMed ID: 12588488
[TBL] [Abstract][Full Text] [Related]
53. PUVA-induced pityriasis lichenoides chronica-like papular lesions in patients with mycosis fungoides: a clinical, histopathological and immunohistochemical study.
Youssef R; Abdel-Halim MRE; Abdel Halim DM; Fawzy MM; Hussein MF; Elmasry MF; Sayed SS; Abo Eid NM
Arch Dermatol Res; 2019 Nov; 311(9):673-678. PubMed ID: 31300833
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma.
Duvic M; Olsen EA; Breneman D; Pacheco TR; Parker S; Vonderheid EC; Abuav R; Ricker JL; Rizvi S; Chen C; Boileau K; Gunchenko A; Sanz-Rodriguez C; Geskin LJ
Clin Lymphoma Myeloma; 2009 Dec; 9(6):412-6. PubMed ID: 19951879
[TBL] [Abstract][Full Text] [Related]
55. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
[TBL] [Abstract][Full Text] [Related]
56. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.
Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654
[TBL] [Abstract][Full Text] [Related]
57. Mycosis fungoides and Sézary syndrome.
Jonak C; Tittes J; Brunner PM; Guenova E
J Dtsch Dermatol Ges; 2021 Sep; 19(9):1307-1334. PubMed ID: 34541796
[TBL] [Abstract][Full Text] [Related]
58. Mycosis fungoides-type cutaneous T-cell lymphoma and neutrophilic dermatosis.
Franck N; Carlotti A; Gorin I; Buffet M; Mateus C; Dupin N
Arch Dermatol; 2005 Mar; 141(3):353-6. PubMed ID: 15781676
[TBL] [Abstract][Full Text] [Related]
59. Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.
Duvic M; Vu J
Biologics; 2007 Dec; 1(4):377-92. PubMed ID: 19707308
[TBL] [Abstract][Full Text] [Related]
60. Syringotropic Mycosis Fungoides: A Variant of Folliculotropic or a Distinct Subtype of Adnexotropic Mycosis Fungoides?
Nussbaum D; Eleryan M; Samaan C; Glass F; Prussick R
J Drugs Dermatol; 2022 Dec; 21(12):1362-1364. PubMed ID: 36468959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
